Trials / Completed
CompletedNCT02572713
Systemic Synuclein Sampling Study (S4)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure alpha-synuclein in peripheral body tissues and fluids in Parkinson's disease (PD). This may help in developing better treatments for PD patients in the future.
Detailed description
This is a multi-center, cross-sectional, observational study to evaluate α-syn pathology in multiple tissues and biofluids in individual subjects with PD and HC at a single time point.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biofluid samplings | Biofluid samplings (blood, saliva, and cerebrospinal fluid (CSF) |
| PROCEDURE | Tissue samplings | Tissue samplings (skin, colon, submandibular gland) |
| DRUG | DaTSCAN™ |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2015-10-09
- Last updated
- 2017-08-17
Locations
6 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02572713. Inclusion in this directory is not an endorsement.